• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India.非酒精性脂肪性肝病与代谢综合征有关联吗？来自印度西孟加拉邦一所医学院的经验。
J Family Med Prim Care. 2025 Jun;14(6):2346-2350. doi: 10.4103/jfmpc.jfmpc_1702_24. Epub 2025 Jun 30.
2
Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada.突破界限：解析印度和加拿大儿童中与代谢功能障碍相关的脂肪性肝病
Can Liver J. 2024 Feb 26;7(3):327-337. doi: 10.3138/canlivj-2023-0023. eCollection 2024 Aug.
3
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率：NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.
4
The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden.1990年至2021年非酒精性脂肪性肝病（包括肝硬化）对老年人的全球影响及疾病负担的未来预测。
PLoS One. 2025 Jun 25;20(6):e0325961. doi: 10.1371/journal.pone.0325961. eCollection 2025.
5
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study.基于人工智能的心脏CT衰减扫描检测肝脂肪变性及综合肝脏评估可增强全因死亡风险分层：一项多中心研究
medRxiv. 2025 Jun 11:2025.06.09.25329157. doi: 10.1101/2025.06.09.25329157.
6
Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.累积甲氨蝶呤剂量与有中重度银屑病病史患者的肝纤维化无关。
Br J Dermatol. 2024 Jul 16;191(2):275-283. doi: 10.1093/bjd/ljae069.
7
Sexual Harassment and Prevention Training性骚扰与预防培训
8
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.用于非酒精性脂肪性肝病和非酒精性脂肪性肝炎的他汀类药物。
Cochrane Database Syst Rev. 2013 Dec 27;2013(12):CD008623. doi: 10.1002/14651858.CD008623.pub2.
9
Heterogeneity of cardiometabolic and hepatic fibrosis risks in nonalcoholic fatty liver disease among lean, overweight, and obese populations: a multicenter cross-sectional study.非酒精性脂肪性肝病中，瘦、超重和肥胖人群中心血管代谢及肝纤维化风险的异质性：一项多中心横断面研究。
Eur J Gastroenterol Hepatol. 2025 Aug 1;37(8):975-981. doi: 10.1097/MEG.0000000000002977. Epub 2025 Jun 18.
10
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充：一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.

本文引用的文献

1
Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.尼泊尔一家三级护理医院的非酒精性脂肪性肝病患者的代谢综合征及生化变化
BMC Gastroenterol. 2018 Jul 6;18(1):109. doi: 10.1186/s12876-018-0843-6.
2
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).代谢综合征的各个组成部分会增加非酒精性脂肪性肝病（NAFLD）的死亡风险。
Medicine (Baltimore). 2018 Mar;97(13):e0214. doi: 10.1097/MD.0000000000010214.
3
Non-alcoholic Fatty Liver Disease: A Clinical Update.非酒精性脂肪性肝病：临床最新进展
J Clin Transl Hepatol. 2017 Dec 28;5(4):384-393. doi: 10.14218/JCTH.2017.00013. Epub 2017 Jul 26.
4
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
5
Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome.非酒精性脂肪性肝病患者的临床特征及其与代谢综合征的关联研究
J Assoc Physicians India. 2015 Jan;63(1):12-6.
6
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.非酒精性脂肪性肝病：代谢综合征的前驱病变
Dig Liver Dis. 2015 Mar;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. Epub 2014 Nov 18.
7
The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.南亚人代谢综合征：流行病学、决定因素与预防。
Metab Syndr Relat Disord. 2009 Dec;7(6):497-514. doi: 10.1089/met.2009.0024.
8
Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.非酒精性脂肪性肝病（NAFLD）——代谢综合征的肝脏组成部分。
J Assoc Physicians India. 2009 Mar;57:201-4.
9
A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中胰岛素抵抗、代谢协变量及预测评分的病例对照研究
Indian J Med Res. 2009 Mar;129(3):285-92.
10
Metabolic syndrome and NASH.代谢综合征与非酒精性脂肪性肝炎。
Clin Liver Dis. 2007 Feb;11(1):105-17, ix. doi: 10.1016/j.cld.2007.02.013.

非酒精性脂肪性肝病与代谢综合征有关联吗？来自印度西孟加拉邦一所医学院的经验。

Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India.

作者信息

Sinha Sounak, Yasmin Shamima, Patra Manas, Sinha Nirmalya, Ahmed Ashfaque

机构信息

Undergraduate MBBS student, Institute of Post-Graduate Medical Eduaction and Research, Kolkata, West Bengal, India.

Department of Community Medicine, Calcutta Medical College, Kolkata, West Bengal, India.

出版信息

J Family Med Prim Care. 2025 Jun;14(6):2346-2350. doi: 10.4103/jfmpc.jfmpc_1702_24. Epub 2025 Jun 30.

DOI:10.4103/jfmpc.jfmpc_1702_24
PMID:40726710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12296318/
Abstract

INTRODUCTION

Nonalcoholic fatty liver disease (NAFLD), a wide spectrum of liver disease ranged from mild steatosis to advance fibrosis, cirrhosis, liver failure and hepato-cellular carcinoma, showed rising trend globally. Prevalent evidences support coexistence between NAFDL and metabolic syndrome.

AIMS

The present study aims to demonstrate the sociodemographic and clinical profile of nonalcoholic fatty liver diseases and its association with metabolic syndrome if any.

MATERIALS AND METHODS

The present cross-sectional study was conducted among the 120 patients diagnosed as NAFLD by ultrasonography as well as similar numbers of matching controls in a tertiary care teaching hospital of eastern part of India. Relevant anthropometric measurements, laboratory investigations and imaging techniques were performed. Metabolic syndrome was classified by the 'International Diabetes Federation, 2005' criteria. Pearson's chi-square test used for measures of association, and < 0.05 was taken as level of significance.

RESULTS

The overall prevalence of metabolic syndrome among the NAFLD study population was 64.2%. Significant positive association found with several cardiometabolic components such as increased body mass index, central obesity, hypertension, fasting blood sugar, dyslipidaemia and NAFLD.

CONCLUSION

The prevalence of metabolic syndrome among NAFLD patients was found quite high and significant positive association found between metabolic syndrome and its components and NAFLD. Early detection of NAFLD might play a vital role in preventive cardiology.

摘要

引言

非酒精性脂肪性肝病（NAFLD）是一种范围广泛的肝脏疾病，从轻度脂肪变性到进展性纤维化、肝硬化、肝衰竭和肝细胞癌，在全球呈上升趋势。现有证据支持NAFLD与代谢综合征并存。

目的

本研究旨在阐明非酒精性脂肪性肝病的社会人口统计学和临床特征及其与代谢综合征（若有）的关联。

材料与方法

本横断面研究在印度东部一家三级护理教学医院中，对120例经超声诊断为NAFLD的患者以及数量相当的匹配对照进行。进行了相关人体测量、实验室检查和影像学检查。代谢综合征根据“国际糖尿病联盟，2005”标准进行分类。采用Pearson卡方检验进行关联性分析，以P<0.05作为显著性水平。

结果

NAFLD研究人群中代谢综合征的总体患病率为64.2%。发现与多个心脏代谢成分存在显著正相关，如体重指数增加、中心性肥胖、高血压、空腹血糖、血脂异常和NAFLD。

结论

NAFLD患者中代谢综合征的患病率相当高，且代谢综合征及其组分与NAFLD之间存在显著正相关。NAFLD的早期检测可能在预防心脏病学中发挥至关重要的作用。